Patents by Inventor Jennifer Louise SCHMIDT

Jennifer Louise SCHMIDT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
    Patent number: 11969407
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Grant
    Filed: November 2, 2023
    Date of Patent: April 30, 2024
    Assignee: TRANSCEND THERAPEUTICS, INC.
    Inventors: Blake Mandell, Martin Stogniew, Jennifer Louise Schmidt, Markus Seelig
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20240058301
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: November 2, 2023
    Publication date: February 22, 2024
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20230338333
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: June 28, 2023
    Publication date: October 26, 2023
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin Stogniew, Jennifer Louise Schmidt, Markus Seelig
  • Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
    Patent number: 11707446
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: July 25, 2023
    Assignee: TRANSCEND THERAPEUTICS, INC.
    Inventors: Blake Mandell, Martin Stogniew, Jennifer Louise Schmidt, Markus Seelig
  • PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS
    Publication number: 20230054211
    Abstract: The invention relates to psychoactive medicines including 2C-B, methylone, MBDB, their respective metabolites, isomers, enantiomers, polymorphs, and analogues (2C-series and cathinones); their preparation, formulations, intermediates, routes of administration, dosing and schedule for medical uses for psychiatric and neurological conditions and disorders.
    Type: Application
    Filed: August 15, 2022
    Publication date: February 23, 2023
    Applicant: Transcend Therapeutics, Inc.
    Inventors: Blake MANDELL, Martin STOGNIEW, Jennifer Louise SCHMIDT, Markus SEELIG